Image: imagefruit, via Getty Images
“Vicious cycle” is hindering innovation among small companies, says UK BioIndustry Association
The UK life sciences sector is being held back by reduced investment and higher costs, according to a new report.
Published on 8 May by the Medicines Discovery Catapult, the UK BioIndustry Association and the Association of the British Pharmaceutical Industry, the report examines the impact of recent economic instability on companies in the life sciences sector.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.